SP1 and autoimmune disease: The identified targets TGFBR1 and IGF1R have been shown to be downregulated in blood cells of patients with autoimmune disease [21] and a loss of SP1 and knockdown of GNAI1 have been described to impair hematopoiesis and immune cell migration capability, respectively [22,23].